The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers "JPI-289"

Completed

Phase 1 Results N/A

Update History

13 Sep '14
The eligibility criteria were updated.
New
Inclusion Criteria: - 19~55 years healthy male - BMI measurement 20kg/m²~27kg/m² - 90 ≤ SBP<140(mmHg) 60 ≤ DBP<100(mmHg) 45 ≤ Pulse rate<100(bpm) - Signed the informed consent from to participate voluntarily and to comply with the trial requirements - For a follow-up visit and during the study period, blood samples and availability Exclusion Criteria: - History of clinically significant hepatic, gastrointestinal, pulmonary, musculoskeletal, endocrine, psychiatric, hematooncologic, cardiovascular (Specially asthma, obstructive pulmonary disease, peptic ulcer) - History of skin disease of graft affecting absorption of the drug - History of drug abuse - Positive urine drug screening - Administrated investigational product in a previous clinical trial within 60 days of the screening test - Donated blood within 60 days prior to screening test
Old
Inclusion Criteria: - 19~55 years healthy male - BMI measurement 20kg/m²~27kg/m² - 90 ≤ SBP<140(mmHg) 60 ≤ DBP<100(mmHg) 45 ≤ Pulse rate<100(bpm) - Signed the informed consent from to participate voluntarily and to comply with the trial requirements - For a follow-up visit and during the study period, blood samples and availability Exclusion Criteria: - History of clinically significant hepatic, gastrointestinal, pulmonary, musculoskeletal, endocrine, psychiatric, hematoncologic, cardiovascular (Specially asthma, obstructive pulmonary disease, peptic ulcer) - History of skin disease of graft affecting absorption of the drug - History of drug abuse - Positive urine drug screening - Administrated investigational product in a previous clinical trial within 60 days of the screening test - Donated blood within 60 days prior to screening test
A location was updated in Seoul.
New
The overall status was removed for Asan Medical Center.